"For GLP-1 patients, I usually prioritize protein first and fiber-rich whole foods
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease (FLOW, NCT03819153) is currently recruiting, and its primary endpoint is a composite outcome defined as persistent eGFR decline of greater than or equal to 50%, reaching ESKD, death from kidney disease or death from CV disease
Life Sci 276:119399 Li M et al (2020) Long Noncoding RNA LINC00460 Promotes Cell Progression by Sponging miR-4443 in Head and Neck Squamous Cell Carcinoma
A new study just published shows that older people have slower processing speed in the brain at B12 levels in the lower half of the reference range
By digging into these mechanisms, were beginning to answer some of these questions, said co-corresponding author Andrew Lutas, Ph.D., an investigator at NIHs National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Contact us today and see why were the #1 choice for wellness solutions across Texas